HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES

• 收藏
• 分享

专利权人:

Viracta Therapeutics, Inc.;Nantkwest, Inc.

发明人:

James N. WOODY,Patrick SOON-SHIONG

申请号：

US16317766

公开号：

US20190290646A1

申请日:

2017.07.14

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Provided are methods and compositions for the treatment of cancer. The methods comprise administering to a subject an HDAC inhibitor and an immunotherapeutic agent. In certain instances the immunotherapeutic is an NK cell or a chimeric antigen receptor NK cell.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/